Antitubercular therapy-induced psychosis

Neurology. 2019 Dec 3;93(23):1012-1013. doi: 10.1212/WNL.0000000000008578.

Authors

Bhanudeep Singanamala¹, Lokesh Saini², Priyanka Madaan¹, Paramjeet Singh¹, Pankaj C Vaidya¹, Jitendra Kumar Sahu¹

Affiliations

¹ From the Pediatric Neurology Unit, Department of Pediatrics, Advanced Pediatrics Centre (B.S., L.S., P.M., P.C.V., J.K.S.), and Department of Radiodiagnosis (P.S.), Post Graduate Institute of Medical Education & Research, Chandigarh; and Council of Scientific and Industrial Research (P.M.), New Delhi, India.
² From the Pediatric Neurology Unit, Department of Pediatrics, Advanced Pediatrics Centre (B.S., L.S., P.M., P.C.V., J.K.S.), and Department of Radiodiagnosis (P.S.), Post Graduate Institute of Medical Education & Research, Chandigarh; and Council of Scientific and Industrial Research (P.M.), New Delhi, India. drlokeshsaini@gmail.com.

PMID: 31792104
DOI: 10.1212/WNL.0000000000008578

No abstract available

Publication types

Case Reports

MeSH terms

Antitubercular Agents / adverse effects*
Child
Cycloserine / adverse effects*
Drug Therapy, Combination / methods
Female
Humans
Psychoses, Substance-Induced / etiology*
Tuberculosis, Multidrug-Resistant / drug therapy*

Substances

Antitubercular Agents
Cycloserine